Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2000 Nov 18;321(7271):1252-5.
doi: 10.1136/bmj.321.7271.1252.

Final results from 10 year cohort of patients undergoing surveillance for Barrett's oesophagus: observational study

C E Macdonald  1 , A C Wicks, R J Playford
Affiliations

Final results from 10 year cohort of patients undergoing surveillance for Barrett's oesophagus: observational study

C E Macdonald et al. BMJ. .

Abstract

Objectives: To review the benefit of an endoscopic surveillance programme for patients with Barrett's oesophagus.

Design: Observational study.

Setting: University teaching hospital.

Participants: 409 patients in whom Barrett's oesophagus was identified during 1984-94; 143 were entered into the annual surveillance programme.

Main outcome measures: Development of dysplasia and cancer and mortality.

Results: The average period of surveillance was 4.4 years; 55 patients were reassessed in 1994 but only eight remained in the programme in 1999, withdrawal being due to death (not from carcinoma of the oesophagus), illness, or frailty. Five of the patients who entered surveillance developed carcinoma of the oesophagus. Only one cancer was identified as a result of a surveillance endoscopy, the others being detected during endoscopy to investigate altered symptoms. Of the 266 patients who were not suitable for surveillance, one died from oesophageal cancer and 103 from other causes. Surveillance has resulted in 745 endoscopies and about 3000 biopsy specimens.

Conclusion: The current surveillance strategy has limited value, and it may be appropriate to restrict surveillance to patients with additional risk factors such as stricture, ulcer, or long segment (>80 mm) Barrett's oesophagus.

PubMed Disclaimer

Comment in

References

    1. Spechler SJ, Robbins AH, Rubins HB, Vincent ME, Heeren T, Doos WG, et al. Adenocarcinoma and Barrett's esophagus. An overrated risk? Gastroenterology. 1984;87:927–933. - PubMed
    1. Cameron AJ, Ott J, Payne WS. The incidence of adenocarcinoma in columnar lined (Barrett's) esophagus. N Engl J Med. 1985;313:857–859. - PubMed
    1. Spechler SJ, Goyal RK. The columnar-lined esophagus, intestinal metaplasia, and Norman Barrett. Gastroenterology. 1996;110:614–621. - PubMed
    1. Wilson JMG, Junger G. Principles and practice of screening for disease. Geneva: World Health Organization; 1968.
    1. Macdonald CE, Wicks AC, Playford RJ. Ten years' experience of screening patients with Barrett's oesophagus in a university teaching hospital. Gut. 1997;41:303–307. - PMC - PubMed